These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11518045)

  • 1. Evaluation and reinforcement of the correlation of S-phase fraction with nodal metastases, tumor grade and tumor size in breast carcinoma patients in Pakistan.
    Bakhtawar H; Ali NM; Khan S; Aziz SA; Sliddiqui T; Pervez S
    Pathol Res Pract; 2001; 197(8):531-6. PubMed ID: 11518045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
    Pervez S; Khan MN; Nasir MI
    J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer.
    Kang HS; Youn YK; Oh SK; Choe KJ; Noh DY
    Breast Cancer Res Treat; 2000 Sep; 63(1):81-7. PubMed ID: 11079162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
    Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.
    Zanon C; Durando A; Geuna M; Clara R; Mobiglia A; Massobrio M; Palestro G; Pourshayesteh A
    Am J Clin Oncol; 1998 Aug; 21(4):392-7. PubMed ID: 9708640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes.
    El-Deftar MF; El Gerzawi SM; Abdel-Azim AA; Tohamy SM
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):7-14. PubMed ID: 23587227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer.
    Merkel DE; Winchester DJ; Goldschmidt RA; August CZ; Wruck DM; Rademaker AW
    Cancer; 1993 Sep; 72(6):1926-32. PubMed ID: 8364870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
    Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
    Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
    Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.